Photorefractive Keratectomy Enhancement

Purpose: To determine rates of enhancement and visual prognosis following photorefractive keratectomy (PRK) enhancement of small-incision lenticule extraction (SMILE). Patients and Methods: This retrospective, single-site study reviewed all cases of primary SMILE at Hoopes Vision in Draper, Utah bet...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical ophthalmology (Auckland, N.Z.) N.Z.), 2022-09, Vol.16, p.3033
Hauptverfasser: Moshirfar, Majid, Parsons, Mark T, Chartrand, Nicholas A, Lau, Chap-Kay, Stapley, Seth, Bundogji, Nour, Ronquillo, Yasmyne C, Hoopes, Phillip C
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page 3033
container_title Clinical ophthalmology (Auckland, N.Z.)
container_volume 16
creator Moshirfar, Majid
Parsons, Mark T
Chartrand, Nicholas A
Lau, Chap-Kay
Stapley, Seth
Bundogji, Nour
Ronquillo, Yasmyne C
Hoopes, Phillip C
description Purpose: To determine rates of enhancement and visual prognosis following photorefractive keratectomy (PRK) enhancement of small-incision lenticule extraction (SMILE). Patients and Methods: This retrospective, single-site study reviewed all cases of primary SMILE at Hoopes Vision in Draper, Utah between March 14, 2017 and April 8, 2022 to identify any cases that required follow-up enhancement. Primary SMILE was performed using Visumax 500 kHz femtosecond laser (Carl Zeiss Meditec, Jena, Germany). All enhancements were performed with alcoholassisted PRK, using a WaveLight EX500 excimer laser (Alcon Laboratories, Inc., Fort Worth, TX). Results: Four hundred and five eyes underwent primary SMILE, of which 15 later underwent PRK enhancement (enhancement rate of 3.7%). No significant difference in pre-SMILE data was identified between the enhancement and non-enhancement groups. The average age of those who underwent PRK enhancement was 33.8[+ or -]6.3 years old and ranged from 25 to 45. Following primary SMILE, 13 eyes (87%) had an uncorrected distance visual acuity (UDVA) of 20/40 or better, and none had a UDVA of 20/20 or better. After one year of post-enhancement follow-up, all eyes had a UDVA of 20/40 or better, and 13 eyes (87%) had a UDVA of 20/20 or better (Figure 1). All were within one diopter of target spherical equivalent (SEQ), 13 (87%) were within 0.50 D, and 10 (67%) were within 0.25 D. Of those with 12-month follow-up data, none had UDVA worse than corrected distance visual acuity (CDVA), and none had lost lines of CDVA. Efficacy and safety indices were 1.03 and 0.99, respectively. Conclusion: Following SMILE, ophthalmologists may anticipate an enhancement rate of one to seven percent. In these cases, PRK is a safe and effective procedure for enhancement of SMILE. Keywords: retreatment, LASIK, refractive surgery, myopia, astigmatism, SMILE
doi_str_mv 10.2147/OPTH.S381319
format Article
fullrecord <record><control><sourceid>gale</sourceid><recordid>TN_cdi_gale_infotracmisc_A722451067</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A722451067</galeid><sourcerecordid>A722451067</sourcerecordid><originalsourceid>FETCH-LOGICAL-g987-e3cc1c948d287acbb01e804cd21a98d4f3551c5026a3f6d16ecc6b2c73bbdade3</originalsourceid><addsrcrecordid>eNptjkFLw0AUhPegYK3e_AEFQU-J-3aT3c2xlNqKhRbMvWzevjSRZBeSVfDfG9BDBZnDwPDNMIzdAU8FZPppfyi36Zs0IKG4YDMArZM8M_KKXY_jO-dKcKNn7PHQhBgGqgeLsf2kxSsNNhLG0H8t1r6xHqknH2_YZW27kW5_fc7K53W52ia7_eZltdwlp8LohCQiYJEZJ4y2WFUcyPAMnQBbGJfVMs8Bcy6UlbVyoAhRVQK1rCpnHck5u_-ZPdmOjq2vQ5yO9e2Ix6UWIsuBKz1R6T_UJEd9i8FT3U75n8LDWaEh28VmDN1HbIMfz8FvroVdHg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Photorefractive Keratectomy Enhancement</title><source>Taylor &amp; Francis Open Access</source><source>DOVE Medical Press Journals</source><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central Open Access</source><source>PubMed Central</source><creator>Moshirfar, Majid ; Parsons, Mark T ; Chartrand, Nicholas A ; Lau, Chap-Kay ; Stapley, Seth ; Bundogji, Nour ; Ronquillo, Yasmyne C ; Hoopes, Phillip C</creator><creatorcontrib>Moshirfar, Majid ; Parsons, Mark T ; Chartrand, Nicholas A ; Lau, Chap-Kay ; Stapley, Seth ; Bundogji, Nour ; Ronquillo, Yasmyne C ; Hoopes, Phillip C</creatorcontrib><description>Purpose: To determine rates of enhancement and visual prognosis following photorefractive keratectomy (PRK) enhancement of small-incision lenticule extraction (SMILE). Patients and Methods: This retrospective, single-site study reviewed all cases of primary SMILE at Hoopes Vision in Draper, Utah between March 14, 2017 and April 8, 2022 to identify any cases that required follow-up enhancement. Primary SMILE was performed using Visumax 500 kHz femtosecond laser (Carl Zeiss Meditec, Jena, Germany). All enhancements were performed with alcoholassisted PRK, using a WaveLight EX500 excimer laser (Alcon Laboratories, Inc., Fort Worth, TX). Results: Four hundred and five eyes underwent primary SMILE, of which 15 later underwent PRK enhancement (enhancement rate of 3.7%). No significant difference in pre-SMILE data was identified between the enhancement and non-enhancement groups. The average age of those who underwent PRK enhancement was 33.8[+ or -]6.3 years old and ranged from 25 to 45. Following primary SMILE, 13 eyes (87%) had an uncorrected distance visual acuity (UDVA) of 20/40 or better, and none had a UDVA of 20/20 or better. After one year of post-enhancement follow-up, all eyes had a UDVA of 20/40 or better, and 13 eyes (87%) had a UDVA of 20/20 or better (Figure 1). All were within one diopter of target spherical equivalent (SEQ), 13 (87%) were within 0.50 D, and 10 (67%) were within 0.25 D. Of those with 12-month follow-up data, none had UDVA worse than corrected distance visual acuity (CDVA), and none had lost lines of CDVA. Efficacy and safety indices were 1.03 and 0.99, respectively. Conclusion: Following SMILE, ophthalmologists may anticipate an enhancement rate of one to seven percent. In these cases, PRK is a safe and effective procedure for enhancement of SMILE. Keywords: retreatment, LASIK, refractive surgery, myopia, astigmatism, SMILE</description><identifier>ISSN: 1177-5483</identifier><identifier>DOI: 10.2147/OPTH.S381319</identifier><language>eng</language><publisher>Dove Medical Press Limited</publisher><subject>Lasers in medicine ; Photorefractive keratectomy</subject><ispartof>Clinical ophthalmology (Auckland, N.Z.), 2022-09, Vol.16, p.3033</ispartof><rights>COPYRIGHT 2022 Dove Medical Press Limited</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>315,782,786,866,27931,27932</link.rule.ids></links><search><creatorcontrib>Moshirfar, Majid</creatorcontrib><creatorcontrib>Parsons, Mark T</creatorcontrib><creatorcontrib>Chartrand, Nicholas A</creatorcontrib><creatorcontrib>Lau, Chap-Kay</creatorcontrib><creatorcontrib>Stapley, Seth</creatorcontrib><creatorcontrib>Bundogji, Nour</creatorcontrib><creatorcontrib>Ronquillo, Yasmyne C</creatorcontrib><creatorcontrib>Hoopes, Phillip C</creatorcontrib><title>Photorefractive Keratectomy Enhancement</title><title>Clinical ophthalmology (Auckland, N.Z.)</title><description>Purpose: To determine rates of enhancement and visual prognosis following photorefractive keratectomy (PRK) enhancement of small-incision lenticule extraction (SMILE). Patients and Methods: This retrospective, single-site study reviewed all cases of primary SMILE at Hoopes Vision in Draper, Utah between March 14, 2017 and April 8, 2022 to identify any cases that required follow-up enhancement. Primary SMILE was performed using Visumax 500 kHz femtosecond laser (Carl Zeiss Meditec, Jena, Germany). All enhancements were performed with alcoholassisted PRK, using a WaveLight EX500 excimer laser (Alcon Laboratories, Inc., Fort Worth, TX). Results: Four hundred and five eyes underwent primary SMILE, of which 15 later underwent PRK enhancement (enhancement rate of 3.7%). No significant difference in pre-SMILE data was identified between the enhancement and non-enhancement groups. The average age of those who underwent PRK enhancement was 33.8[+ or -]6.3 years old and ranged from 25 to 45. Following primary SMILE, 13 eyes (87%) had an uncorrected distance visual acuity (UDVA) of 20/40 or better, and none had a UDVA of 20/20 or better. After one year of post-enhancement follow-up, all eyes had a UDVA of 20/40 or better, and 13 eyes (87%) had a UDVA of 20/20 or better (Figure 1). All were within one diopter of target spherical equivalent (SEQ), 13 (87%) were within 0.50 D, and 10 (67%) were within 0.25 D. Of those with 12-month follow-up data, none had UDVA worse than corrected distance visual acuity (CDVA), and none had lost lines of CDVA. Efficacy and safety indices were 1.03 and 0.99, respectively. Conclusion: Following SMILE, ophthalmologists may anticipate an enhancement rate of one to seven percent. In these cases, PRK is a safe and effective procedure for enhancement of SMILE. Keywords: retreatment, LASIK, refractive surgery, myopia, astigmatism, SMILE</description><subject>Lasers in medicine</subject><subject>Photorefractive keratectomy</subject><issn>1177-5483</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid/><recordid>eNptjkFLw0AUhPegYK3e_AEFQU-J-3aT3c2xlNqKhRbMvWzevjSRZBeSVfDfG9BDBZnDwPDNMIzdAU8FZPppfyi36Zs0IKG4YDMArZM8M_KKXY_jO-dKcKNn7PHQhBgGqgeLsf2kxSsNNhLG0H8t1r6xHqknH2_YZW27kW5_fc7K53W52ia7_eZltdwlp8LohCQiYJEZJ4y2WFUcyPAMnQBbGJfVMs8Bcy6UlbVyoAhRVQK1rCpnHck5u_-ZPdmOjq2vQ5yO9e2Ix6UWIsuBKz1R6T_UJEd9i8FT3U75n8LDWaEh28VmDN1HbIMfz8FvroVdHg</recordid><startdate>20220930</startdate><enddate>20220930</enddate><creator>Moshirfar, Majid</creator><creator>Parsons, Mark T</creator><creator>Chartrand, Nicholas A</creator><creator>Lau, Chap-Kay</creator><creator>Stapley, Seth</creator><creator>Bundogji, Nour</creator><creator>Ronquillo, Yasmyne C</creator><creator>Hoopes, Phillip C</creator><general>Dove Medical Press Limited</general><scope/></search><sort><creationdate>20220930</creationdate><title>Photorefractive Keratectomy Enhancement</title><author>Moshirfar, Majid ; Parsons, Mark T ; Chartrand, Nicholas A ; Lau, Chap-Kay ; Stapley, Seth ; Bundogji, Nour ; Ronquillo, Yasmyne C ; Hoopes, Phillip C</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-g987-e3cc1c948d287acbb01e804cd21a98d4f3551c5026a3f6d16ecc6b2c73bbdade3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Lasers in medicine</topic><topic>Photorefractive keratectomy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Moshirfar, Majid</creatorcontrib><creatorcontrib>Parsons, Mark T</creatorcontrib><creatorcontrib>Chartrand, Nicholas A</creatorcontrib><creatorcontrib>Lau, Chap-Kay</creatorcontrib><creatorcontrib>Stapley, Seth</creatorcontrib><creatorcontrib>Bundogji, Nour</creatorcontrib><creatorcontrib>Ronquillo, Yasmyne C</creatorcontrib><creatorcontrib>Hoopes, Phillip C</creatorcontrib><jtitle>Clinical ophthalmology (Auckland, N.Z.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Moshirfar, Majid</au><au>Parsons, Mark T</au><au>Chartrand, Nicholas A</au><au>Lau, Chap-Kay</au><au>Stapley, Seth</au><au>Bundogji, Nour</au><au>Ronquillo, Yasmyne C</au><au>Hoopes, Phillip C</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Photorefractive Keratectomy Enhancement</atitle><jtitle>Clinical ophthalmology (Auckland, N.Z.)</jtitle><date>2022-09-30</date><risdate>2022</risdate><volume>16</volume><spage>3033</spage><pages>3033-</pages><issn>1177-5483</issn><abstract>Purpose: To determine rates of enhancement and visual prognosis following photorefractive keratectomy (PRK) enhancement of small-incision lenticule extraction (SMILE). Patients and Methods: This retrospective, single-site study reviewed all cases of primary SMILE at Hoopes Vision in Draper, Utah between March 14, 2017 and April 8, 2022 to identify any cases that required follow-up enhancement. Primary SMILE was performed using Visumax 500 kHz femtosecond laser (Carl Zeiss Meditec, Jena, Germany). All enhancements were performed with alcoholassisted PRK, using a WaveLight EX500 excimer laser (Alcon Laboratories, Inc., Fort Worth, TX). Results: Four hundred and five eyes underwent primary SMILE, of which 15 later underwent PRK enhancement (enhancement rate of 3.7%). No significant difference in pre-SMILE data was identified between the enhancement and non-enhancement groups. The average age of those who underwent PRK enhancement was 33.8[+ or -]6.3 years old and ranged from 25 to 45. Following primary SMILE, 13 eyes (87%) had an uncorrected distance visual acuity (UDVA) of 20/40 or better, and none had a UDVA of 20/20 or better. After one year of post-enhancement follow-up, all eyes had a UDVA of 20/40 or better, and 13 eyes (87%) had a UDVA of 20/20 or better (Figure 1). All were within one diopter of target spherical equivalent (SEQ), 13 (87%) were within 0.50 D, and 10 (67%) were within 0.25 D. Of those with 12-month follow-up data, none had UDVA worse than corrected distance visual acuity (CDVA), and none had lost lines of CDVA. Efficacy and safety indices were 1.03 and 0.99, respectively. Conclusion: Following SMILE, ophthalmologists may anticipate an enhancement rate of one to seven percent. In these cases, PRK is a safe and effective procedure for enhancement of SMILE. Keywords: retreatment, LASIK, refractive surgery, myopia, astigmatism, SMILE</abstract><pub>Dove Medical Press Limited</pub><doi>10.2147/OPTH.S381319</doi></addata></record>
fulltext fulltext
identifier ISSN: 1177-5483
ispartof Clinical ophthalmology (Auckland, N.Z.), 2022-09, Vol.16, p.3033
issn 1177-5483
language eng
recordid cdi_gale_infotracmisc_A722451067
source Taylor & Francis Open Access; DOVE Medical Press Journals; DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central Open Access; PubMed Central
subjects Lasers in medicine
Photorefractive keratectomy
title Photorefractive Keratectomy Enhancement
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-04T23%3A35%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Photorefractive%20Keratectomy%20Enhancement&rft.jtitle=Clinical%20ophthalmology%20(Auckland,%20N.Z.)&rft.au=Moshirfar,%20Majid&rft.date=2022-09-30&rft.volume=16&rft.spage=3033&rft.pages=3033-&rft.issn=1177-5483&rft_id=info:doi/10.2147/OPTH.S381319&rft_dat=%3Cgale%3EA722451067%3C/gale%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rft_galeid=A722451067&rfr_iscdi=true